Literature DB >> 21734552

Efficacy of novel collagen/gelatin scaffold with sustained release of basic fibroblast growth factor for dermis-like tissue regeneration.

Norikazu Kanda1, Naoki Morimoto, Satoru Takemoto, Artem A Ayvazyan, Katsuya Kawai, Yuki Sakamoto, Tsuguyoshi Taira, Shigehiko Suzuki.   

Abstract

We have developed collagen/gelatin sponges (CGS) with a gelatin concentration of 10 wt% to sustain the release of basic fibroblast growth factor (bFGF). The objective of this study is to elucidate the efficacy of CGS impregnated with different concentrations of bFGF, using mouse skin defects. CGSs impregnated with normal saline solution (NSS) or bFGF solution (1, 7, 14, or 50 μg/cm) were implanted into full-thickness skin defects on the backs of mice. The wound area, neoepithelium length, and total area of newly formed capillaries in CGS were evaluated. The group of CGS with 7-μg/cm bFGF was significantly superior to the NSS group in all evaluated items. CGS impregnated with the appropriate dosage of bFGF accelerates dermis-like tissue formation 2 or 3 times earlier than existing artificial dermis. The combination of CGS and bFGF could solve the problem of the existing artificial dermis and be very promising for the treatment of skin defects.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21734552     DOI: 10.1097/SAP.0b013e318222832f

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  8 in total

1.  Collagen-gelatin mixtures as wound model, and substrates for VEGF-mimetic peptide binding and endothelial cell activation.

Authors:  Tania R Chan; Patrick J Stahl; Yang Li; S Michael Yu
Journal:  Acta Biomater       Date:  2015-01-10       Impact factor: 8.947

2.  An exploratory clinical trial for combination wound therapy with a novel medical matrix and fibroblast growth factor in patients with chronic skin ulcers: a study protocol.

Authors:  Naoki Morimoto; Kenichi Yoshimura; Miyuki Niimi; Tatsuya Ito; Harue Tada; Satoshi Teramukai; Toshinori Murayama; Chikako Toyooka; Satoru Takemoto; Katsuya Kawai; Masayuki Yokode; Akira Shimizu; Shigehiko Suzuki
Journal:  Am J Transl Res       Date:  2012-01-05       Impact factor: 4.060

Review 3.  Drug delivery systems for wound healing.

Authors:  Noah R Johnson; Yadong Wang
Journal:  Curr Pharm Biotechnol       Date:  2015       Impact factor: 2.837

4.  Development of gelatin hydrogel nonwoven fabrics (Genocel®) as a novel skin substitute in murine skin defects.

Authors:  Yuanjiaozi Li; Eiichi Sawaragi; Michiharu Sakamoto; Takashi Nakano; Hiroki Yamanaka; Itaru Tsuge; Kumiko Matsuno; Yasuhiko Tabata; Naoki Morimoto
Journal:  Regen Ther       Date:  2022-06-21       Impact factor: 3.651

5.  Optimal amount of basic fibroblast growth factor in gelatin sponges incorporating β-tricalcium phosphate with chondrocytes.

Authors:  Yushi Otani; Makoto Komura; Hiroko Komura; Tetsuya Ishimaru; Kenichiro Konishi; Hiroaki Komuro; Kazuto Hoshi; Tsuyoshi Takato; Yasuhiko Tabata; Tadashi Iwanaka
Journal:  Tissue Eng Part A       Date:  2015-01-20       Impact factor: 3.845

Review 6.  The Japanese Experience with Basic Fibroblast Growth Factor in Cutaneous Wound Management and Scar Prevention: A Systematic Review of Clinical and Biological Aspects.

Authors:  Mohamed Abdelhakim; Xunxun Lin; Rei Ogawa
Journal:  Dermatol Ther (Heidelb)       Date:  2020-06-06

7.  The sustained release of basic fibroblast growth factor accelerates angiogenesis and the engraftment of the inactivated dermis by high hydrostatic pressure.

Authors:  Tien Minh Le; Naoki Morimoto; Toshihito Mitsui; Sharon Claudia Notodihardjo; Maria Chiara Munisso; Natsuko Kakudo; Kenji Kusumoto
Journal:  PLoS One       Date:  2019-02-21       Impact factor: 3.240

8.  The Effect of Control-released Basic Fibroblast Growth Factor in Wound Healing: Histological Analyses and Clinical Application.

Authors:  Shigeru Matsumoto; Rica Tanaka; Kayoko Okada; Kayo Arita; Hiko Hyakusoku; Masaaki Miyamoto; Yasuhiko Tabata; Hiroshi Mizuno
Journal:  Plast Reconstr Surg Glob Open       Date:  2013-10-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.